Bottom line
QAAHBX vs SWHFX: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and SWHFX (Schwab Health Care Fund) are both etfs.
But QAAHBX is far broader, holding 277 positions to 80 for SWHFX, so beyond the top names it adds exposure SWHFX doesn't have.
SWHFX is cheaper at 0.8% vs 1.11% — a difference of $31 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +3.9% for QAAHBX.
Updated Nov 19, 2026
QAAHBX vs SWHFX side by side
| QAAHBX | SWHFX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | T. Rowe Price | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.8% |
| Annual cost per $10k | $111 | $80 |
| 10-yr cost on $10k (prospectus) | $1,352 | $990 |
| Max front load | None | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +17.8% | +15.9% |
| 5-yr return (annualized) | +3.9% | +6.5% |
| 10-yr return (annualized) | +8.7% | +8.1% |
| Best quarter | +23.4% | +15.3% |
| Worst quarter | −15.8% | −12.1% |
| Net assets (fund) | $751.7M | $642.3M |
| Number of holdings | 277 | 80 |
| Portfolio turnover | 65% | 41% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of QAAHBX's top 25 holdings also appear in SWHFX's top 25.
| Holding | QAAHBX | SWHFX |
|---|---|---|
| Eli Lilly & Co | 14.06% | 13.92% |
| Johnson & Johnson | 6.64% | 6.94% |
| Unitedhealth Group Inc | 5.88% | 4.74% |
| Abbvie Inc | 5.12% | 5.81% |
| Merck & Co. Inc. | 4.00% | 4.98% |
| Gilead Sciences Inc | 2.79% | 3.24% |
| Thermo Fisher Scientific Inc | 2.53% | 2.16% |
| Vertex Pharmaceuticals Inc | 2.26% | 1.89% |
| Bristol-myers Squibb Co | 2.12% | 2.44% |
| Abbott Laboratories | 1.91% | 1.60% |
| Amgen Inc | 1.80% | 2.58% |
| Stryker Corp | 1.78% | 2.11% |
| Elevance Health Inc | 1.54% | 1.45% |
| Danaher Corp | 1.44% | 1.47% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between QAAHBX and SWHFX?
Which is cheaper, QAAHBX or SWHFX?
Should I own both QAAHBX and SWHFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.